Proposed approval of the new active constituent, G-Protein (sG) of Hendra Virus, and registration of the product Equivac HeV Hendra Virus Vaccine for Horses

The APVMA is considering an application for the approval of the new active constituent, G-Protein (sG) of Hendra Virus, and registration of the product Equivac HeV Hendra Virus Vaccine for Horses Equivac WNV.

We invite comment from 17 June 2014 to 15 July 2014 on whether the application for registration should be granted.

The APVMA is able to consider comments relating to the legislative grounds for registration, including:

• occupational health and safety
• safety and first aid
• chemistry and manufacture
• residues
• environmental fate and toxicity
• trade
• efficacy.

For more information, see page 25 of Gazette No. 12 – 17 June 2014.

Please send your written submission by email, post or fax to:

Veterinary Medicines Program
Case Management and Administration Unit
Australian Pesticides and Veterinary Medicines Authority
PO Box 6182
Kingston ACT 2604

Email: vetmedicines@apvma.gov.au
Fax: +61 2 6210 4721

For enquiries, please call +61 2 6210 4701.